Hyloris Pharmaceuticals SA

EBR:HYL.BR

5.3 (EUR) • At close February 19, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) EUR.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 2.7012.7012.322.321.5271.5270.580.580.6770.6771.0330.5162.2581.1290.8380.4190.0470.0470.0190.0630.0080.0080.0350.04
Kosten van de omzet 0.060.060.0540.0540.0240.0240.0230.0230.0170.0170.0610.0310.1090.0330.0420.0210.0180.0180.0890.020.0150.0150.0140.023
Brutowinst 2.6422.6422.2662.2661.5041.5040.5570.5570.6610.6610.9720.4862.1491.0970.7960.3980.0290.029-0.070.043-0.007-0.0070.0210.017
Brutowinstmarge 0.9780.9780.9770.9770.9850.9850.960.960.9760.9760.9410.9410.9520.9710.950.950.6130.613-3.6840.683-0.813-0.8130.60.425
Onderzoek- en ontwikkelingskosten 2.4762.4762.6572.6573.7753.7753.4363.4362.782.784.7122.3563.4961.7481.560.781.1211.1210.3880.7841.8791.8790.3760.443
Algemene en administratieve kosten 1.2391.2391.5751.5752.77300000001.4491.449000.1310.1311.9310.5230.2460.2460.180.136
Verkoop- en marketingkosten 0000-1.2450000000-0.201-0.80300-0.001-0.001000.0010.00100
Verkoop-, algemene en administratieve kosten 1.2391.2391.5751.5751.5281.5281.2451.2451.1221.1221.2740.6371.2480.6461.6080.8040.130.131.9310.5230.2460.2460.180.136
Overige kosten 0.5040.5040.0230.0230.6470000000000000-0.02000-0.0720
Bedrijfskosten 4.2194.2194.2544.2545.956.0524.1074.1074.0984.0985.9862.9154.7442.4993.1684.3741.5931.5932.2991.3072.1182.1180.4840.579
Bedrijfsresultaat -1.577-1.577-1.988-1.988-4.447-4.415-3.508-3.508-3.345-3.345-5.014-2.409-2.595-4.13-2.372-1.033-0.722-0.722-2.369-1.264-0.523-0.523-0.463-0.562
Bedrijfsresultaat ratio -0.584-0.584-0.857-0.857-2.912-2.891-6.048-6.048-4.941-4.941-4.854-4.664-1.149-3.658-2.831-2.464-15.516-15.516-124.684-20.063-65.375-65.375-13.229-14.05
Totaal overige inkomsten en kosten netto 0.1490.1490.2460.2460.0740.0420.1910.191-0.135-0.1352.543-0.0331.074-0.207-6.096-0.164-0.006-0.0060.207-0.315-0.11-0.11-0.164-0.124
Inkomen voor belasting -1.429-1.429-1.743-1.743-4.373-4.373-3.317-3.317-3.48-3.48-5.08-2.471-3.01-1.521-8.468-4.12-1.702-1.702-2.162-1.579-2.234-2.234-0.629-0.685
Inkomen voor belasting ratio -0.529-0.529-0.751-0.751-2.864-2.864-5.719-5.719-5.14-5.14-4.918-4.784-1.333-1.347-10.105-9.833-36.591-36.591-113.789-25.063-279.188-279.188-17.971-17.125
Belastingkosten 000000000.0020.002-0.19600.2160.149-0.3060000.4760.0010.0070.007-0.0490.006
Nettowinst -1.429-1.429-1.743-1.743-4.373-4.373-3.317-3.317-3.482-3.482-4.942-2.471-3.339-1.67-8.24-4.12-1.702-1.702-2.638-1.58-2.148-2.148-0.58-0.691
Nettowinstmarge -0.529-0.529-0.751-0.751-2.864-2.864-5.719-5.719-5.143-5.143-4.784-4.784-1.479-1.479-9.833-9.833-36.591-36.591-138.842-25.079-268.438-268.438-16.571-17.275
WPA (Winst Per Aandeel) -0.049-0.049-0.06-0.06-0.16-0.16-0.12-0.12-0.12-0.12-0.19-0.095-0.13-0.065-0.32-0.16-0.067-0.067-0.1-0.067-0.2-0.2-0.025-0.029
Verwaterde WPA -0.049-0.049-0.06-0.06-0.16-0.16-0.12-0.12-0.12-0.12-0.19-0.094-0.13-0.065-0.32-0.16-0.066-0.066-0.1-0.067-0.2-0.2-0.025-0.029
EBITDA -0.61-0.61-1.815-1.815-4.389-4.37-3.427-3.427-3.335-3.335-2.382-2.382-4.117-4.117-1.02-1.02-0.71-0.71-1.764-1.36-0.51-0.51-0.526-0.541
EBITDA ratio -0.226-0.226-0.782-0.782-2.874-2.862-5.908-5.908-4.926-4.926-2.305-4.611-1.823-3.647-1.217-2.433-15.258-15.258-92.842-21.587-63.812-63.812-15.029-13.525